Diabetes Flashcards
5 types of oral hypoglycemics
Buguanides (metformin)
Sulfonylureas (glicazide and glipiside)
Thizolidinediones (rosiglitazone, pioglotazone)
A-glycosidase inhibitors (acarbose, voglibose)
DPP4 inhibitor
Type 2 DM
Insulin sensitivity, body not producing enough insulin or body isn’t using it correctly
Pancreas has alpha and beta endocrine cells
Alpha create glucagon
Beta create insulin
Type 1 diabetes mellitus
Is complete destruction of the beta cells of the endocrine portion of the pancreas - islet of langerhans
Glycogenolysis
Glycogen - glucose
Glycogenesis
Glucose - glycogen
Lipolysis
Fatty acid - ketones
use of stored energy from cells
Insulin maintains usually, if not enough they roam freely in the blood
Fasting plasma glucose normal levels
<6mmol
4.4-5.6mmol
Hba1c
Average of glucose level over 10-12 weeks
Signs and symptoms of diabetes type 1
Polydipsia, polyuria, polyphagia, lethargy, fatigue, blurred vision, younger patient, ketoacidosis, fruity smelling breath
Signs of hyperglycaemic hyperosmolar syndrome
Hypovolemia, hyperglycaemia, dehydration, glucosuria over a longer period of time than DKA
Long acting insulin
Isophane
Insulin lispro
Fast acting taken around time of eating often called Humalog
Insulin aspart
Rapid acting insulin
Metabolism is
reactions involving degradation, synthesis and transformation of energy rich organic molecules. During digestion, molecules are broken down into smaller, absorbable subunits –> monosaccharides (glucose) which are absorbed in the bloodstream.
Endocrine portion of the pancreas includes
Islets of Langerhans containing alpha cells for glucagon and beta cells for insulin and amylin
Amylin..
Delays gastric emptying and suppresses glucagon post meals
Glucose
is the main source of energy for most body cells, levels are maintained by pancreas hemostasis by endocrine portion.
An increased BGL level…
promotes insulin release from beta cells of the pancreas
Insulin
binds to kinase receptors and stimulates glucose uptake from blood GLUC2 transporter, stimulating glycogen formation (glycogenesis) in the liver to decrease glucose output and decrease BGL
A decreased BGL
promotes alpha cells to release glucagon from endocrine pancreas which is transported by GLUC2 transporter to stimulate the breakdown of glycogen = glycogenolysis
MOA of biguanides (metformin)
Suppresses hepatic glucose release and increases peripheral uptake of glucose
MOA of sulfonylureas
Summon insulin / stimulate B cell secretion
Thiazolidinediones MOA
increase the effect of insulin especially on muscle and fat cells, increase peripheral uptake of glucose
a-glucosidase inhibitors
inhibit the alpha pancreas endocrine cells to reduce glucagon release